Insider Trading & Ownership - Anand Bhaskar

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Anand Bhaskar
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-05
Sale
2023-09-07
4:11 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
406$169.2$68,69524,089
(Direct)
View
2023-08-15
Sale
2023-08-17
4:31 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
403$168.72$67,99524,495
(Direct)
View
2023-06-14
Sale
2023-06-16
4:03 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
2,343$102.11$239,24848,336
(Direct)
View
2023-05-15
Sale
2023-05-17
4:26 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
1,086$85.37$92,71425,679
(Direct)
View
2023-03-07
Sale
2023-03-08
5:08 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
165$84.58$13,95626,765
(Direct)
View
2023-03-03
Sale
2023-03-06
4:31 pm
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
820$87.47$71,72526,930
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-11
Option Award
2024-09-13
5:26 pm
N/A
N/A
Summit Therapeutics Inc.SMMTAnand Bhaskar
Chief Accounting Officer
22,026$22.7131,426
(Direct)
View
2024-04-02
Option Award
2024-04-04
5:47 pm
N/A
2034-04-02
Summit Therapeutics Inc.SMMTAnand Bhaskar
Chief Accounting Officer
600,000$0600,000
(Direct)
View

Ownership
2024-04-04
5:43 pm
N/A
N/A
Summit Therapeutics Inc.SMMTAnand Bhaskar
Chief Accounting Officer
0$0109,400
(Direct)
View
2023-09-26
Disposition
2023-09-26
4:30 pm
N/A
2031-07-12
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
102,027$00
(Direct)
View
2023-06-14
Exercise
2023-06-16
4:03 pm
N/A
2032-01-03
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
1,562$048,336
(Direct)
View
2023-06-14
Exercise
2023-06-16
4:03 pm
N/A
N/A
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
1,562$27.3248,336
(Direct)
View
2023-03-01
Option Award
2023-03-02
5:15 pm
N/A
2032-05-20
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer
9,000$033,750
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:07 pm
N/A
2033-01-03
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
VP, Chief Accounting Officer
41,750$058,250
(Direct)
View
2022-01-03
Option Award
2022-01-05
4:10 pm
N/A
2032-01-03
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
VP, Chief Accounting Officer
37,500$041,500
(Direct)
View

Ownership
2021-11-15
10:16 am
N/A
N/A
REATA PHARMACEUTICALS INCRETAAnand Bhaskar
VP, Chief Accounting Officer
0$019,000
(Direct)
View